223 related articles for article (PubMed ID: 31678857)
1. Patients' expectations of autologous hematopoietic stem cell transplantation as a treatment for MS.
De Kleermaeker FGCM; Uitdehaag BMJ; van Oosten BW
Mult Scler Relat Disord; 2020 Jan; 37():101467. PubMed ID: 31678857
[TBL] [Abstract][Full Text] [Related]
2. [Multiple sclerosis: interventions to halt disease : Which patients can be considered for autologous stem cell transplantation].
Willison AG; Meuth SG
Nervenarzt; 2022 Oct; 93(10):987-999. PubMed ID: 35951049
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Bose G; Thebault S; Rush CA; Atkins HL; Freedman MS
Mult Scler; 2021 Feb; 27(2):167-173. PubMed ID: 32364422
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of autografting persons with multiple sclerosis are better in those not exposed to prior disease-modifying therapies.
Sánchez-Bonilla D; Robles-Nasta M; Gallardo-Pérez MM; Hernández-Flores EJ; Montes-Robles M; Pastelín-Martínez ML; Garcés-Eisele SJ; Olivares-Gazca JC; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Mult Scler Relat Disord; 2023 Jul; 75():104744. PubMed ID: 37178580
[TBL] [Abstract][Full Text] [Related]
6. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Muraro PA; Pasquini M; Atkins HL; Bowen JD; Farge D; Fassas A; Freedman MS; Georges GE; Gualandi F; Hamerschlak N; Havrdova E; Kimiskidis VK; Kozak T; Mancardi GL; Massacesi L; Moraes DA; Nash RA; Pavletic S; Ouyang J; Rovira M; Saiz A; Simoes B; Trnený M; Zhu L; Badoglio M; Zhong X; Sormani MP; Saccardi R;
JAMA Neurol; 2017 Apr; 74(4):459-469. PubMed ID: 28241268
[TBL] [Abstract][Full Text] [Related]
8. aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.
Häußler V; Ufer F; Pöttgen J; Wolschke C; Friese MA; Kröger N; Heesen C; Stellmann JP
Ann Clin Transl Neurol; 2021 Jun; 8(6):1269-1278. PubMed ID: 33949790
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis.
Bose G; Freedman MS
J Neurol Sci; 2021 Feb; 421():117324. PubMed ID: 33497951
[TBL] [Abstract][Full Text] [Related]
10. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.
Das J; Snowden JA; Burman J; Freedman MS; Atkins H; Bowman M; Burt RK; Saccardi R; Innocenti C; Mistry S; Laud PJ; Jessop H; Sharrack B
Mult Scler; 2021 Jul; 27(8):1198-1204. PubMed ID: 33565902
[TBL] [Abstract][Full Text] [Related]
11. Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa Protocol.
Puyade M; Brunet F; Carolina R; Fergusson N; Makedonov I; Freedman MS; Atkins H
Curr Protoc; 2022 May; 2(5):e437. PubMed ID: 35594180
[TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
13. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
Massey JC; Sutton IJ; Ma DDF; Moore JJ
Front Immunol; 2018; 9():410. PubMed ID: 29593711
[TBL] [Abstract][Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
[TBL] [Abstract][Full Text] [Related]
15. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Lachnit M; Revendova KZ; Hradilek P; Bunganic R; Koristek Z; Jelinek T; Skutova M; Piza R; Volny O; Hajek R; Bar M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):50-54. PubMed ID: 37337857
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis.
Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DD; Moore JJ; Massey JC
Mult Scler; 2021 Nov; 27(13):2112-2115. PubMed ID: 33870788
[TBL] [Abstract][Full Text] [Related]
17. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis.
Ross LA; Stropp LM; Cohen JA
Neurol Clin; 2024 Feb; 42(1):165-184. PubMed ID: 37980114
[TBL] [Abstract][Full Text] [Related]
18. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
[TBL] [Abstract][Full Text] [Related]
19. Impact of Immunoablation and Autologous Hematopoietic Stem Cell Transplantation on Treatment Cost of Multiple Sclerosis: Real-World Nationwide Study.
Orlewska K; Bogusz K; Podlecka-Piętowska A; Nojszewska M; Markiewicz M; Liwoch R; Orlewski P; Śliwczyński A; Zakrzewska-Pniewska B; Snarski E
Value Health Reg Issues; 2021 Sep; 25():104-107. PubMed ID: 33865219
[TBL] [Abstract][Full Text] [Related]
20. Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists.
Das J; Sharrack B; Snowden JA
Curr Hematol Malig Rep; 2019 Apr; 14(2):127-135. PubMed ID: 30828772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
